Xesso Neo Spray
NDC Package 81777-106-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Xesso Neo (benzocaine) sprays is apply to the affected area (one spray). This formulation utilizes a spray delivery system. Marketed by Premium Natural Cosmetics Inc, this product is identified by NDC 81777-106 and is authorized under FDA application M013.

Identification & Billing

NDC Package Code
81777-106-04
Package Description
59 mL in 1 BOTTLE, SPRAY
Product Code
11-Digit Billing Format
81777010604

Clinical Specifications

Proprietary Name
Xesso Neo
Non-Proprietary Name
Benzocaine
Substance Name
Benzocaine
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
  • Oral - Administration to or by way of the mouth.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Apply to the affected area (one spray). Allow to remain in place for at least 15 seconds then spit out. May be repeated every two hours as needed or as directed by a health care professional.

Regulatory & Marketing

Labeler Name
Premium Natural Cosmetics Inc
Product Type
Human Otc Drug
FDA Application #
M013
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-16-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81777-106-04 identifies a specific commercial package of 59 ml in 1 bottle, spray of Xesso Neo, a human over the counter drug labeled by Premium Natural Cosmetics Inc. This spray is formulated for oral; topical use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Premium Natural Cosmetics Inc on April 16, 2024. The current certification is valid through December 31, 2026.

How is this Premium Natural Cosmetics Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81777010604. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81777-106-04
11-Digit CMS (5-4-2)
81777-0106-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.